Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Nørgaard-Pedersen
Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125)
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Related publications
CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers
Cancer
Cancer Research
Oncology
Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Second-Line Treatment of Ovarian Cancer
Oncologist
Cancer Research
Medicine
Oncology
EP25.09: Comparison of Diagnostic Value of Using GIRADS System and Ovarian Malignancy Marker Ca-125 in the Preoperational Adnexal Tumours Assessment
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
KIM-1 as a Potential Serological/Urinological Tumor-Associated Marker of Renal Cell Carcinoma and Chemotherapy Nephrotoxicity
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
The Role of CA‐125 in the Management of Ovarian Cancer
Oncologist
Cancer Research
Medicine
Oncology
Second-Line Treatment Options in Hepatocellular Carcinoma
Drugs in Context
Molecular Medicine
Pharmacology
YKL-40/CHI3L1 Drives Inflammation on the Road of Tumor Progression
Journal of Leukocyte Biology
Allergy
Immunology
Cell Biology
CA 19-9 and CA 125 Determination by Immunoluminometric Assay
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
